Live Breaking News & Updates on ஒன்றுபட்டது கிஂக்டம் பல்கலைக்கழகம் ஆஃப் கிழக்கு ஆங்கிலியா

Stay updated with breaking news from ஒன்றுபட்டது கிஂக்டம் பல்கலைக்கழகம் ஆஃப் கிழக்கு ஆங்கிலியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pharmacies Could Soon Offer Customized, 3D-Printed Medication On Demand


A 3D printer. (Image by Graftencom from Pixabay via Courthouse News)
(CN) The days of waiting some time for a pharmacist to fill a prescription made by your doctor may soon be behind us.
Pharmacies, doctors’ offices and other medical institutions could one day offer individual patients medications that are customized to their needs using 3D printing technology. The new technology has been developed in recent years under an expanding field of pharmaceutical research aiming to understand how to shape the effect medication has on patients. 
The 3D-printed pill model could spark a wave of personalized pharmacological interventions tailored to meet the unique needs of all patients, according to lead researcher of the study Sheng Qi.   ....

United Kingdom , Sheng Qi , Andy Gleadall , Richard Bibb , International Journal Of Pharmaceutics , United Kingdom University Of East Anglia , England Loughborough University , Courthouse News , East Anglia , International Journal , Loughborough University , ஒன்றுபட்டது கிஂக்டம் , ஷெங் குய் , ரிச்சர்ட் பிப் , ஒன்றுபட்டது கிஂக்டம் பல்கலைக்கழகம் ஆஃப் கிழக்கு ஆங்கிலியா , இங்கிலாந்து ல Ough பரோ பல்கலைக்கழகம் , நீதிமன்றம் செய்தி , கிழக்கு ஆங்கிலியா , சர்வதேச இதழ் , ல Ough பரோ பல்கலைக்கழகம் ,

Lancet Analysis of Sputnik V Puts It Among World's Top Vaccines, Medical Scientist Says


To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International ....

South Africa , United Kingdom , South African , Kirill Dmitriev , Russian Health Ministry , Microbiology Center , Russian Direct Investment Fund , Astrazeneca Oxford University , Hungarian Foreign Ministry , Russian Healthcare Ministry , European Union , United Kingdom University Of East Anglia , Russian Ministry Of Health On , United Kingdom Department Of Health , United Kingdom University , East Anglia , Hungarian Foreign , Gamaleya Epidemiology , Russian Ministry , Mixed Sputnikv Astrazeneca Dosing Ongoing , May Lead , Sputnikv Astrazeneca , United Kingdom Department , Social Care , Oxford University , Russian Health ,

Lancet publishes Sputnik V Phase III clinical trial data, showing Russian Covid-19 vaccine is 91%+ effective


Follow RT on
In a major breakthrough for Russia’s Sputnik V Covid-19 vaccine, the prestigious British medical journal The Lancet has published preliminary Phase III trial results showing it is highly effective – notably, for all age groups.
Data from 19,866 volunteers – 4,902 of whom were in the placebo group – showed that Sputnik V had an overall efficacy of 91.6 percent, rising to 91.8 percent among the group of 2,144 volunteers over the age of 60, according to the interim results of the Phase III clinical trial published in the Lancet on Tuesday.
At the end of the study, there were 62 confirmed Covid-19 cases in the placebo group and only 16 in the vaccine group. Sputnik V proved to be 100 percent effective in preventing the development of severe cases. ....

United Kingdom , Cecil Czerkinsky , Alexander Gintsburg , Hildegund Ertl , Kirill Dmitriev , David Livermore , French National Institute Of Health , United Kingdom University Of East Anglia , Gamaleya Research Institute , Wistar Institute , Russian Direct Investment Fund , French National Institute , East Anglia , Medical Microbiology David Livermore , Professor Hildegund Ertl , ஒன்றுபட்டது கிஂக்டம் , டேவிட் லிவர்மோர் , பிரஞ்சு தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் , ஒன்றுபட்டது கிஂக்டம் பல்கலைக்கழகம் ஆஃப் கிழக்கு ஆங்கிலியா , ரஷ்ய நேரடி முதலீடு நிதி , பிரஞ்சு தேசிய நிறுவனம் , கிழக்கு ஆங்கிலியா , மருத்துவ நுண்ணுயிரியல் டேவிட் லிவர்மோர் ,

Lancet study finds Sputnik V more than 91% effective against Covid-19, 100% in preventing severe cases -- Health & Wellness -- Sott.net


© Global Look Press / Patricio Murphy
Sputnik V vaccine In a major breakthrough for Russia s Sputnik V Covid-19 vaccine, the prestigious British medical journal
The Lancet has published preliminary Phase III trial results showing it is highly effective - notably,
for all age groups.
Comment: This is important because the experimental and unproven Pfizer and Moderna vaccines have little to no data on the efficacy for the at risk age groups.
Data from
19,866 volunteers - 4,902 of whom were in the placebo group - showed that Sputnik V had an overall efficacy of 91.6 percent, rising to 91.8 percent among the group of 2,144 volunteers over the age of 60, according to the interim results of the Phase III clinical trial published in the ....

United Kingdom , Cecil Czerkinsky , Alexander Gintsburg , Hildegund Ertl , Kirill Dmitriev , David Livermore , Global Look Press Patricio Murphy Sputnik , French National Institute Of Health , United Kingdom University Of East Anglia , Gamaleya Research Institute , Wistar Institute , Russian Direct Investment Fund , Global Look Press , Patricio Murphy , French National Institute , East Anglia , Medical Microbiology David Livermore , Professor Hildegund Ertl , ஒன்றுபட்டது கிஂக்டம் , டேவிட் லிவர்மோர் , உலகளாவிய பாருங்கள் ப்ரெஸ் பேட்ரிஸியோ மர்பி ஸ்பட்நிக் , பிரஞ்சு தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் , ஒன்றுபட்டது கிஂக்டம் பல்கலைக்கழகம் ஆஃப் கிழக்கு ஆங்கிலியா , ரஷ்ய நேரடி முதலீடு நிதி , உலகளாவிய பாருங்கள் ப்ரெஸ் , பேட்ரிஸியோ மர்பி ,